Niagen Bioscience (NAGE) Reports Next Week: What to Expect

Company Overview - Niagen Bioscience (NAGE) is expected to report flat earnings of $0.02 per share for the quarter ended September 2025, with revenues projected at $31.3 million, reflecting a 22.4% increase year-over-year [3][12]. Earnings Expectations - The upcoming earnings report is scheduled for November 4, and the stock may experience upward movement if earnings exceed expectations, while a miss could lead to a decline [2][12]. - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates a negative Earnings ESP of -33.33% for Niagen Bioscience, suggesting analysts have become bearish on the company's earnings prospects [12]. - The stock currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Niagen Bioscience exceeded the consensus EPS estimate of $0.02 by delivering earnings of $0.04, resulting in a surprise of +100.00% [13]. - The company has successfully beaten consensus EPS estimates in all of the last four quarters [14]. Industry Context - In the broader context of the Zacks Medical - Biomedical and Genetics industry, Liquidia Corporation (LQDA) is expected to report a loss of $0.45 per share, with revenues anticipated to rise by 250.6% year-over-year [18][19].